GGP Inc. (GGP) retreated with the stock falling -1.07% or $-0.27 to close at $25.03 on light trading volume of 2.88M compared its three months average trading volume of 4.3M. The Chicago Illinois 60606 based company operating under the REIT – Retail industry has been trending down for the last 52 weeks, with the shares price now -2.53% down for the period and up by 0.2% so far this year. With price target of $29.97 and a 5.3% rebound from 52-week low, GGP Inc. has plenty of upside potential, making it a hold with a view buy.
General Growth Properties, Inc is an equity real estate investment trust. The firm invests in the real estate markets of the United States. It engages in owning, managing, leasing, and redeveloping high-quality regional malls. General Growth Properties, Inc is based in Chicago, Illinois.
The Dow Chemical Company (DOW) had a light trading with around 4.51M shares changing hands compared to its three month average trading volume of 6.34M. The stock traded between $60.63 and $61.74 before closing at the price of $61.72 with 0.26% change on the day. The Midland Michigan 48674 based company is currently trading 38.96% above its 52 week low of $46.18 and -0.21% below its 52 week high of $61.85. Both the RSI indicator and target price of and $66.78 respectively, lead us to believe that it could rise over the coming weeks.
The Dow Chemical Company manufactures and supplies products that are used primarily as raw materials in the manufacture of customer products and services worldwide. It operates through five segments: Agricultural Sciences, Consumer Solutions, Infrastructure Solutions, Performance Materials & Chemicals, and Performance Plastics segments. The Agricultural Sciences segment provides crop protection and seed/plant biotechnology products and technologies, urban pest management solutions, and healthy oils. The Consumer Solutions segment offers semiconductors and organic light-emitting diodes, adhesives, and foams for use in the transportation industry; cellulosics and other polymers for pharmaceutical formulations and food solutions; and silicone solutions used in consumer goods and automotive applications. The Infrastructure Solutions segment provides architectural and industrial coatings, construction material ingredients, building insulation products, adhesives, and microbial protection products for the oil and gas industry, telecommunications, and light and water technologies. The Performance Materials & Chemicals segment offers chlorine and caustic soda; industrial solutions; and propylene oxides, propylene glycols, polyether polyols, and aromatic isocyanates. The Performance Plastics segment provides elastomers, polyolefin plastomers, and ethylene propylene diene monomer elastomers; wire and cable insulation, semiconductive, and jacketing compound solutions, as well as bio-based plasticizers; acrylics, polyethylene, and polyolefin plastomers; and ethylene, propylene, benzene, butadiene, octene, aromatics co-products, and crude c4. The company was founded in 1897 and is based in Midland, Michigan.
DaVita Inc. (DVA) saw its value decrease by -0.12% as the stock dropped $-0.08 to finish the day at a closing price of $64.73. The stock was lighter in trading and has fluctuated between $54.5-$78.77 per share for the past year. The shares, which traded within a range of $64.57 to $65.06 during the day, are up by 8.74% in the past three months and down by -5.27% over the past six months. It is currently trading 0.84% above its 20 day moving average and 0.34% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $65.2 a share over the next twelve months. The current relative strength index (RSI) reading is 54.01.The technical indicator lead us to believe there will be no major movement any time soon, hold.
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). It operates through two divisions, Kidney Care and HealthCare Partners. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers, as well as patient and physician focused integrated health care delivery and management services. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2015, it provided dialysis and administrative services in the United States through a network of 2,251 outpatient dialysis centers serving approximately 180,000 patients; and operated 118 outpatient dialysis centers located in 10 countries outside of the United States. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.